News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Ulrik Lassen, MD, PhD

Articles by Ulrik Lassen, MD, PhD

Diagnosis and Management of TRK Fusion Cancer

ByShivaani Kummar, MD, FACP,Antoine Italiano, MD, PhD,Marcia S. Brose, MD, PhD,Josh J. Carlson, PhD, MPH,Sean D. Sullivan, PhD, MSc, RPh,Ulrik Lassen, MD, PhD,Noah Federman, MD

January 11th 2022

Comparative Effectiveness of Larotrectinib and Entrectinib for TRK Fusion Cancer

ByJosh J. Carlson, PhD, MPH,Antoine Italiano, MD, PhD,Marcia S. Brose, MD, PhD,Noah Federman, MD,Ulrik Lassen, MD, PhD,Shivaani Kummar, MD, FACP,Sean D. Sullivan, PhD, MSc, RPh

January 11th 2022

Latest Updated Articles

Diagnosis and Management of TRK Fusion Cancer
January 11th 2022
Comparative Effectiveness of Larotrectinib and Entrectinib for TRK Fusion Cancer
January 11th 2022

Trending on AJMC

Dual Agonist Survodutide Delivers Up to 13.1% Weight Loss in T2D

CMS Projects 16.5% Drop in 2027 Medicare Advantage Premiums

FDA Accepts Inhaled Treprostinil sNDA for IPF: 4 FAQs for Payers

Oncologists Grapple With Sequencing, Access as Treatments Multiply

Proposed Medicare Rate Cuts Draw AASM Opposition Ahead of Final Rule